Dublin, July 22, 2020 (GLOBE NEWSWIRE) -- The "Human Gene Sequencing Markets, Strategies & Trends, Forecasts by Hereditary, Newborn Screening, NIPT, Oncology, Pharmacogenomic, and Direct To Consumer, by Country, With Executive and Consultant Guides - 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.
Will all newborns receive genetic testing at birth? Why has Direct to Consumer Testing taken a big jump? What's holding the industry back? Where are the over 800 locations that have high throughput sequencing devices?
The plummeting costs for Genome Sequencing are creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions.
Tumour Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Key Topics Covered:
Human Gene Sequencing Markets - Strategic Situation Analysis & COVID Impact
- Guide for Executives, Marketing, Sales and Business Development Staff
- Guide for Management Consultants and Investment Advisors
1. Introduction and Market Definition
1.1 Gene Sequencing Definition In This Report
1.2 The Genomics Revolution
1.3 Market Definition
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.5 Genetic Testing vs. Gene Sequencing
2. Market Overview
2.1 Market Participants Play Different Roles
2.2 Human Gene Sequencing - Markets, Examples and Discussion
3. Market Trends
3.1 Factors Driving Growth
3.2 Factors Limiting Growth
3.3 Sequencing Instrumentation
4. Human Gene Sequencing Recent Developments
- Yourgene Health Gets CE Mark for Iona NIPT Test
- NorthShore Looks to Expand Genomics Integration Into Primary Care
- Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced
- Cancer Patients
- FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
- BillionToOne Closes $15M Series A Follow-on Round
- Mass General, Brigham and Women's Open Clinics to Integrate Genomics Into Primary Care
- Asuragen Fragile X Diagnostic Test Gets FDA Authorization
- Fluxion Bio Wins NIH Grant to Develop NIPT Assay
- Illumina, Broad Institute Collaborate on Genome Analysis Software
- Illumina, Adaptive Biotechnologies Partner on IVD Test Kits for Immune Sequencing
- Menarini Silicon Biosystems, BlueBee Partner on Sequencing Data Analysis Platform
- Paying cash for elective genomic sequencing
- NIH funds Color ahead of million-person sequencing effort
- Veritas Genetics slashes price of whole genome sequencing 40% to $600
- Superfast gene sequencing diagnoses critically ill patients
- Veracyte Details Clinical Utility of RNA Sequencing-Based Testing for Thyroid Cancer
- Longas Technologies Launches. Offers 'Virtual Long Read' Library Prep
- New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier
- PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive
- Health Management
- Roche Gets CE Mark for Mutation Profiler Software for NGS Cancer Tests
- PGDx and PathGroup Enter Co-Development Agreement
- Newborn genomic sequencing detects unanticipated disease risk factors
5. Profiles of Key Companies
6. The Global Market for Human Genome Sequencing
6.1 Global Market Overview by Country
6.2 Global Market by Application - Overview
7. Market Sizes by Application
7.1 Hereditary Gene Sequencing Market
7.2 Newborn Gene Sequencing Market
7.3 NIPT Gene Sequencing Market
7.4 Oncology Gene Sequencing Market
7.5 Pharmacogenomic Gene Sequencing Market
7.6 Direct To Consumer Gene Sequencing Market
8. Vision of the Future of Human Gene Sequencing
Companies Mentioned
- 10x Genomics, Inc
- 23andME Inc
- Abbott Diagnostics
- AccuraGen Inc.
- Adaptive Biotechnologies
- Admera Health, LLC
- Agena Bioscience, Inc
- Agilent
- Akonni Biosystems
- Ancestry.com LLC
- BioGenex
- Biolidics Ltd
- bioMrieux Diagnostics
- Bioneer Corporation
- Cancer Genetics
- Caris Molecular Diagnostics
- CellMax Life
- Centogene
- Fluidigm Corp
- Foundation Medicine
- Freenome
- FUJIFILM Wako Diagnostics
- Fujirebio
- GE Global Research
- Helomics
- Hologic
- Horizon Discovery
- HTG Molecular Diagnostics
- Human Longevity, Inc. iCellate
- Illumina
- Incell Dx
- Inivata
- Integrated Diagnostics
- Invitae Corporation
- Invivoscribe
- Karius
- Macrogen
- MDNA Life SCIENCES, Inc
- MDx Health
- Medgenome
- Meridian Bioscience
- Mesa Biotech
- MIODx
- miR Scientific
- MNG Labs
- Molecular MD
- NantHealth, Inc.
- Natera
- Nebula Genomics
- NeoGenomics
- New Oncology
- Novogene Bioinformatics Technology Co., Ltd.
- Omega Bioservices
- OncoDNA
- ORIG3N, Inc.
- Origene Technologies
- Oxford Nanopore Technologies
- Pacific Biosciences
- Panagene
- Perkin Elmer
- Personal Genome Diagnostics
- Personalis
- Precipio
- PrecisionMed
- Promega
- Protagen Diagnostics
- Qiagen Gmbh
- Quantumdx
- Regeneron
- Roche Molecular Diagnostics
- Roswell Biotechnologies
- Seegene
- Sequencing.com
- Siemens Healthineers
- simfo GmbH
- Singlera Genomics Inc
- SkylineDx
- Stratos Genomics
- Sure Genomics, Inc.
- Sysmex
- Sysmex Inostics
- Tempus Labs, Inc
- Thermo Fisher Scientific Inc
- Veritas Genetics
- Volition
For more information about this report visit https://www.researchandmarkets.com/r/nfo670
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.